MTX-211

MTX-211 is a dual inhibitor of EGFR and PI3K, which plays important roles in the progression of KRAS mutant colorectal cancer. MTX-211 has the potential for the treatment of KRAS mutant colorectal cancer.


Cat. No.: EX-A1821	Purity: >98%

	Chemical structure of MTX-211

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	550	In-stock
250mg	800	In-stock
500mg	1285	In-stock
5g	3855	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


CAS No.	1952236-05-3
Purity	>98%
Formula	C20H14Cl2FN5O2S
Mol Weight	478.327
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Small molecule inhibitors of egfr and pi3k. WO 2016100347 A2.
CoA	CoA of MTX-211

Smiles:	CS(=O)(=O)NC1=C(Cl)N=CC(=C1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(F)C=C1


		Search